HK1110211A1 - - Google Patents
Info
- Publication number
- HK1110211A1 HK1110211A1 HK08101077.6A HK08101077A HK1110211A1 HK 1110211 A1 HK1110211 A1 HK 1110211A1 HK 08101077 A HK08101077 A HK 08101077A HK 1110211 A1 HK1110211 A1 HK 1110211A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- disease
- compound
- parkinson
- treatment
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0504103.3A GB0504103D0 (en) | 2005-02-28 | 2005-02-28 | Novel method |
| PCT/GB2006/000684 WO2006090177A1 (en) | 2005-02-28 | 2006-02-27 | USE OF 2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-l,3- CYCLOHEXANEDIONE IN THE TREATMENT OF PARKINSON'S DISEASE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1110211A1 true HK1110211A1 (ru) | 2008-07-11 |
Family
ID=34430351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08101077.6A HK1110211A1 (ru) | 2005-02-28 | 2008-01-28 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20090326072A1 (ru) |
| EP (1) | EP1853241B1 (ru) |
| JP (1) | JP2008531665A (ru) |
| CN (1) | CN101163466B (ru) |
| AT (1) | ATE524171T1 (ru) |
| AU (1) | AU2006217650B2 (ru) |
| BR (1) | BRPI0609177A2 (ru) |
| CA (1) | CA2598517A1 (ru) |
| DK (1) | DK1853241T3 (ru) |
| ES (1) | ES2374761T3 (ru) |
| GB (1) | GB0504103D0 (ru) |
| HK (1) | HK1110211A1 (ru) |
| IL (1) | IL185410A0 (ru) |
| MX (1) | MX2007010480A (ru) |
| PT (1) | PT1853241E (ru) |
| RU (1) | RU2420272C2 (ru) |
| WO (1) | WO2006090177A1 (ru) |
| ZA (1) | ZA200707486B (ru) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8222243B2 (en) | 2007-08-27 | 2012-07-17 | Dart Neuroscience (Cayman) Ltd | Therapeutic isoxazole compounds |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| EP2356130A4 (en) * | 2008-11-06 | 2012-05-02 | Biotie Therapies Ag | TREATMENT OF NON-REST LEG SYNDROME AND OTHER SLEEP DISORDERS |
| PL2723320T3 (pl) | 2011-06-23 | 2016-06-30 | Swedish Orphan Biovitrum Int Ab | Ciekła kompozycja farmaceutyczna zawierająca nityzynon |
| CN103622942A (zh) * | 2013-11-04 | 2014-03-12 | 江苏大学 | 左旋多巴/卡比多巴复方缓释混悬剂及其制备方法 |
| ITUB20160650A1 (it) | 2016-02-11 | 2017-08-11 | Dipharma S A | Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione |
| US9783485B1 (en) | 2016-11-30 | 2017-10-10 | Dipharma S.A. | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4780127A (en) * | 1982-03-25 | 1988-10-25 | Stauffer Chemical Company | Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides |
| US5092919A (en) * | 1991-01-15 | 1992-03-03 | Imperial Chemical Industries Plc | Certain 2-(2'-methyl-3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones |
| FR2777781B1 (fr) * | 1998-04-24 | 2004-04-09 | Rhone Poulenc Rorer Sa | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
| WO2004005321A2 (en) * | 2002-07-03 | 2004-01-15 | The Rockefeller University | Methods of inhibiting 4-hydroxyphenylpyruvate dioxygenase in a living system |
| WO2005007096A2 (en) * | 2003-07-11 | 2005-01-27 | Merck & Co., Inc. | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| CA2659424A1 (en) * | 2006-08-18 | 2008-02-21 | Syngenta Limited | Use of hppd inhibitors in the treatment of depression and/or withdrawal symptoms associated with addictive drugs |
| EP2356130A4 (en) * | 2008-11-06 | 2012-05-02 | Biotie Therapies Ag | TREATMENT OF NON-REST LEG SYNDROME AND OTHER SLEEP DISORDERS |
-
2005
- 2005-02-28 GB GBGB0504103.3A patent/GB0504103D0/en not_active Ceased
-
2006
- 2006-02-27 ES ES06709910T patent/ES2374761T3/es active Active
- 2006-02-27 MX MX2007010480A patent/MX2007010480A/es not_active Application Discontinuation
- 2006-02-27 DK DK06709910.1T patent/DK1853241T3/da active
- 2006-02-27 CN CN2006800133878A patent/CN101163466B/zh not_active Expired - Fee Related
- 2006-02-27 EP EP06709910A patent/EP1853241B1/en active Active
- 2006-02-27 JP JP2007557572A patent/JP2008531665A/ja active Pending
- 2006-02-27 US US12/090,645 patent/US20090326072A1/en not_active Abandoned
- 2006-02-27 WO PCT/GB2006/000684 patent/WO2006090177A1/en active Application Filing
- 2006-02-27 RU RU2007131934/15A patent/RU2420272C2/ru not_active IP Right Cessation
- 2006-02-27 AT AT06709910T patent/ATE524171T1/de active
- 2006-02-27 PT PT06709910T patent/PT1853241E/pt unknown
- 2006-02-27 BR BRPI0609177-6A patent/BRPI0609177A2/pt not_active IP Right Cessation
- 2006-02-27 CA CA002598517A patent/CA2598517A1/en not_active Abandoned
- 2006-02-27 ZA ZA200707486A patent/ZA200707486B/xx unknown
- 2006-02-27 AU AU2006217650A patent/AU2006217650B2/en not_active Ceased
-
2007
- 2007-08-21 IL IL185410A patent/IL185410A0/en unknown
-
2008
- 2008-01-28 HK HK08101077.6A patent/HK1110211A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200707486B (en) | 2009-02-25 |
| CA2598517A1 (en) | 2006-08-31 |
| AU2006217650B2 (en) | 2011-06-09 |
| JP2008531665A (ja) | 2008-08-14 |
| CN101163466A (zh) | 2008-04-16 |
| IL185410A0 (en) | 2008-08-07 |
| WO2006090177A1 (en) | 2006-08-31 |
| PT1853241E (pt) | 2012-01-11 |
| BRPI0609177A2 (pt) | 2010-02-23 |
| RU2007131934A (ru) | 2009-02-27 |
| MX2007010480A (es) | 2008-02-07 |
| ES2374761T3 (es) | 2012-02-21 |
| DK1853241T3 (da) | 2012-01-16 |
| ATE524171T1 (de) | 2011-09-15 |
| RU2420272C2 (ru) | 2011-06-10 |
| AU2006217650A1 (en) | 2006-08-31 |
| GB0504103D0 (en) | 2005-04-06 |
| CN101163466B (zh) | 2011-12-07 |
| EP1853241A1 (en) | 2007-11-14 |
| US20090326072A1 (en) | 2009-12-31 |
| EP1853241B1 (en) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
| EP2400847A4 (en) | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOIN COMPOUNDS | |
| MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
| EP1940373B8 (en) | 1-fluoro-1-deoxy-scyllo-inositol for the treatment of alzheimer's disease | |
| TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
| GEP20115172B (en) | Bicyclic cinnamide compound | |
| MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
| TW200728307A (en) | Novel spirochromanone derivatives | |
| GEP20115176B (en) | Prodrug of cinnamide compound | |
| HK1152705A1 (en) | Dihydropyrimidine compounds and use thereof for the treatment of viral diseases | |
| HK1110211A1 (ru) | ||
| WO2009071690A3 (de) | 5,6-disubstituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen | |
| EP1855679A4 (en) | INHIBITORS OF AMINOMETHYL BETA-SECRETASE IN THE TREATMENT OF ALZHEIMER'S DISEASE | |
| UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
| DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
| TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
| ZA200700945B (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
| DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
| PT1778837E (pt) | Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4 | |
| WO2008057599A3 (en) | Methods for the treatment of abeta related disorders and compositions therefor | |
| DE602007008947D1 (en) | 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren | |
| ZA200800999B (en) | Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy | |
| WO2008014232A3 (en) | Pharmaceutical formulations for the treatment of alzheimer's disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160227 |